Showing results (431-440 of 446) with videos related to
Sort By:
Pageof 45
JAMA|August 19, 2018
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical TrialRuth Webster, Abdul Salam, H Asita de Silva, et al.Journal of the American College of Cardiology|September 1, 2024
Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of HypertensionAnthony Rodgers, Abdul Salam, Aletta E Schutte, et al.BMJ (Clinical Research Ed.)|May 4, 2022
PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendationsQiukui Hao, Bert Aertgeerts, Gordon Guyatt, et al.Lancet (London, England)|October 19, 2024
Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trialAnthony Rodgers, Abdul Salam, Aletta E Schutte, et al.International Journal of Stroke : Official Journal of the International Stroke Society|January 7, 2022
Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progressCraig S Anderson, Anthony Rodgers, H Asita de Silva, et al.Diabetologia|July 6, 2021
Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose controlJohanne Tremblay, Mounsif Haloui, Redha Attaoua, et al.Global Heart|November 3, 2025
Long-Term Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination for the Treatment of HypertensionAbdul Salam, H Asita de Silva, Dike Ojji, et al.Journal of the American Heart Association|August 24, 2022
Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of HypertensionSonali R Gnanenthiran, Claudio Borghi, Dylan Burger, et al.American Heart Journal|July 24, 2026
Intensive Blood-Pressure Control for the Prevention of Major Cardiovascular Events in Patients with Type 2 Diabetes: Rationale, Design and Baseline Characteristics of the OPTIMAL-DIABETES Randomized TrialKarla Santo, Eduardo Martins, Gisele S Silva, et al.The British Journal of Psychiatry : the Journal of Mental Science|December 18, 2023
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trialColleen Loo, Nick Glozier, David Barton, et al.Pageof 45